- (PLX AI) - AstraZeneca Q2 revenue USD 8,220 million vs. estimate USD 7,530 million.
- • Q2 EPS USD 0.42 vs. estimate USD 0.56
- • Q2 adjusted EPS USD 0.9 vs. estimate USD 0.93
- • New guidance: Total revenue is expected to increase by a low-twenties percentage, accompanied by a faster growth in Core EPS to $5.05 to $5.40